Posted by Michael Wonder on 21 Jan 2025
Health Canada authorises Vabysmo (faricimab injection) pre-filled syringe for three leading causes of vision loss
20 January 2025 - Vabysmo pre-filled syringe is the first and only syringe pre-filled with a Health-Canada approved bispecific antibody to treat retinal conditions that can cause blindness.
Roche Canada is pleased to announce today that Health Canada has authorised Vabysmo (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe for use in the treatment of wet, or neovascular, age-related macular degeneration, diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
